| 1 | modest | 3,716 |
| 2 | slight | 2,147 |
| 3 | non-significant | 1,586 |
| 4 | nonsignificant | 1,473 |
| 5 | 1-point | 67 |
| 6 | 1-sd | 67 |
| 7 | 5-log | 31 |
| 8 | 1-unit | 29 |
| 9 | ≥4-fold | 29 |
| 10 | small-to-moderate | 28 |
| 11 | one-point | 27 |
| 12 | near-significant | 19 |
| 13 | disproportional | 18 |
| 14 | 10-mmhg | 17 |
| 15 | 2-log | 17 |
| 16 | 3-log | 17 |
| 17 | one-unit | 17 |
| 18 | 10-ms | 13 |
| 19 | 10-unit | 13 |
| 20 | 15-letter | 12 |
| 21 | 1-log | 11 |
| 22 | wedge-shaped | 11 |
| 23 | galactogogue | 10 |
| 24 | 4-log | 9 |
| 25 | small-moderate | 9 |
| 26 | trend-level | 9 |
| 27 | ≥1-point | 9 |
| 28 | 1-kg | 8 |
| 29 | 10-mg/dl | 8 |
| 30 | 5-mmhg | 8 |
| 31 | ≥15-letter | 8 |
| 32 | 1-mg/dl | 7 |
| 33 | 5-kg | 7 |
| 34 | 5-unit | 7 |
| 35 | 0.5-point | 6 |
| 36 | 10-letter | 6 |
| 37 | 10°f | 6 |
| 38 | one-category | 6 |
| 39 | record-breaking | 6 |
| 40 | ≥2-point | 6 |
| 41 | 2-grade | 5 |
| 42 | 20-mmhg | 5 |
| 43 | 3-line | 5 |
| 44 | 7-log | 5 |
| 45 | nine-fold | 5 |
| 46 | passable | 5 |
| 47 | sampen | 5 |
| 48 | ser37 | 5 |
| 49 | 0.1-cm | 4 |
| 50 | 0.5mg/dl | 4 |
| 51 | 10-msec | 4 |
| 52 | 4.1-month | 4 |
| 53 | 4.5-log | 4 |
| 54 | 5-bpm | 4 |
| 55 | 6-log | 4 |
| 56 | dose-dependant | 4 |
| 57 | five-unit | 4 |
| 58 | mechanically-induced | 4 |
| 59 | sub-additive | 4 |
| 60 | t-score≤-2.5 | 4 |
| 61 | 0.5-mg/dl | 3 |
| 62 | 1-g/dl | 3 |
| 63 | 1-mmhg | 3 |
| 64 | 1.36-fold | 3 |
| 65 | 10-μg/l | 3 |
| 66 | 1°f | 3 |
| 67 | 2-line | 3 |
| 68 | 2-sd | 3 |
| 69 | 450-bp | 3 |
| 70 | 5-beat | 3 |
| 71 | 5-ms | 3 |
| 72 | 74-fold | 3 |
| 73 | dust-mite | 3 |
| 74 | lf-diet | 3 |
| 75 | mobilizable | 3 |
| 76 | rhytid | 3 |
| 77 | superlative | 3 |
| 78 | teriparatide-induced | 3 |
| 79 | two-grade | 3 |
| 80 | ≥2-log | 3 |
| 81 | -1sd | 2 |
| 82 | -cipiccoc | 2 |
| 83 | 0.06mm | 2 |
| 84 | 0.1-unit | 2 |
| 85 | 0.5-unit | 2 |
| 86 | 0.7/1000 | 2 |
| 87 | 0.8-point | 2 |
| 88 | 1-grade | 2 |
| 89 | 1-met | 2 |
| 90 | 1-natural-log-unit | 2 |
| 91 | 1.08-fold | 2 |
| 92 | 1.8-point | 2 |
| 93 | 1.96-fold | 2 |
| 94 | 10-bpm | 2 |
| 95 | 10-cmh2o | 2 |
| 96 | 10-u | 2 |
| 97 | 10-µm | 2 |
| 98 | 100-ng/ml | 2 |
| 99 | 100pg/ml | 2 |
| 100 | 14-second | 2 |
| 101 | 14.3-fold | 2 |
| 102 | 15-db | 2 |
| 103 | 17.2-fold | 2 |
| 104 | 2-mmhg | 2 |
| 105 | 2.25-fold | 2 |
| 106 | 2.4-point | 2 |
| 107 | 2.5-3-fold | 2 |
| 108 | 25-mg/dl | 2 |
| 109 | 3.1-month | 2 |
| 110 | 3.3-point | 2 |
| 111 | 3.6-day | 2 |
| 112 | 3.74-fold | 2 |
| 113 | 3.94-fold | 2 |
| 114 | 30-mmhg | 2 |
| 115 | 350-fold | 2 |
| 116 | 4.36-fold | 2 |
| 117 | 400-g | 2 |
| 118 | 5.26-fold | 2 |
| 119 | 50-hu | 2 |
| 120 | 6-unit | 2 |
| 121 | 63-fold | 2 |
| 122 | 7.5-day | 2 |
| 123 | 9-log | 2 |
| 124 | candesartan-mediated | 2 |
| 125 | colorectostomy | 2 |
| 126 | direct-to-indirect | 2 |
| 127 | disease-attributable | 2 |
| 128 | drug-independent | 2 |
| 129 | fifteen-fold | 2 |
| 130 | l-nmma-induced | 2 |
| 131 | limb- | 2 |
| 132 | lipohemarthrosis | 2 |
| 133 | luxated | 2 |
| 134 | moderate-to-marked | 2 |
| 135 | one-standard-deviation | 2 |
| 136 | polylactide-based | 2 |
| 137 | post-hypothermic | 2 |
| 138 | redofundoplication | 2 |
| 139 | scr-level | 2 |
| 140 | silicone-covered | 2 |
| 141 | small-to-large | 2 |
| 142 | stroke-risk | 2 |
| 143 | sub-proportional | 2 |
| 144 | well-marked | 2 |
| 145 | ∼2.5-fold | 2 |
| 146 | ∼7-fold | 2 |
| 147 | ≥1/3 | 2 |
| 148 | ≥20-point | 2 |
| 149 | ≥3-fold | 2 |
| 150 | ≥8-point | 2 |
| 151 | 'gfr | 1 |
| 152 | -5-mv | 1 |
| 153 | -5·79 | 1 |
| 154 | .10-mm | 1 |
| 155 | 0.007-mmol/l | 1 |
| 156 | 0.009-mmol/l | 1 |
| 157 | 0.01-s | 1 |
| 158 | 0.03-unit | 1 |
| 159 | 0.1-mg/l | 1 |
| 160 | 0.186-point | 1 |
| 161 | 0.2-ph-unit | 1 |
| 162 | 0.2-point | 1 |
| 163 | 0.241-unit | 1 |
| 164 | 0.25-mg/dl | 1 |
| 165 | 0.4-pound | 1 |
| 166 | 0.43-kcal | 1 |
| 167 | 0.5-l | 1 |
| 168 | 0.5-meq/l | 1 |
| 169 | 0.5-mg/l | 1 |
| 170 | 0.5-mm-step | 1 |
| 171 | 0.55ng/ml | 1 |
| 172 | 0.6-1.0-s | 1 |
| 173 | 0.6-log | 1 |
| 174 | 0.6mmhg | 1 |
| 175 | 0.7-point | 1 |
| 176 | 0.73-point | 1 |
| 177 | 0.78±0.13 | 1 |
| 178 | 0.96-point | 1 |
| 179 | 1,8-cineol-depending | 1 |
| 180 | 1-allele | 1 |
| 181 | 1-beat-per-minute | 1 |
| 182 | 1-log-unit | 1 |
| 183 | 1-mg·h/l | 1 |
| 184 | 1-mug/ml | 1 |
| 185 | 1-ng/ml | 1 |
| 186 | 1-sd-unit | 1 |
| 187 | 1.0-meq/l | 1 |
| 188 | 1.0-point | 1 |
| 189 | 1.05-fold | 1 |
| 190 | 1.10-point | 1 |
| 191 | 1.2-1.4-fold | 1 |
| 192 | 1.2-pound | 1 |
| 193 | 1.21-point | 1 |
| 194 | 1.22-g/dl | 1 |
| 195 | 1.25-ml | 1 |
| 196 | 1.3-day | 1 |
| 197 | 1.3-kg | 1 |
| 198 | 1.53-unit | 1 |
| 199 | 1.6-point | 1 |
| 200 | 1.7-db | 1 |
| 201 | 1.92-point | 1 |
| 202 | 10-30-fold | 1 |
| 203 | 10-g/l | 1 |
| 204 | 10-microg/m3 | 1 |
| 205 | 10-millisecond | 1 |
| 206 | 10-ml/min | 1 |
| 207 | 10-nmol/l | 1 |
| 208 | 10-µg/m3 | 1 |
| 209 | 100-cell/microl | 1 |
| 210 | 100-cgy | 1 |
| 211 | 100-mmol/d | 1 |
| 212 | 100-mum | 1 |
| 213 | 100-ru/ml | 1 |
| 214 | 1000-unit | 1 |
| 215 | 1000/microl | 1 |
| 216 | 10minute/night | 1 |
| 217 | 12.5-point | 1 |
| 218 | 13.8-fold | 1 |
| 219 | 15.5-fold | 1 |
| 220 | 16.3°c | 1 |
| 221 | 17.4-fold | 1 |
| 222 | 19.6-fold | 1 |
| 223 | 2-degree | 1 |
| 224 | 2-kg | 1 |
| 225 | 2-log10 | 1 |
| 226 | 2.0-log | 1 |
| 227 | 2.1-kg | 1 |
| 228 | 2.27-point | 1 |
| 229 | 2.43-fold | 1 |
| 230 | 2.47/log10 | 1 |
| 231 | 2.5-kg | 1 |
| 232 | 2.64-unit | 1 |
| 233 | 2.8-kg | 1 |
| 234 | 2.86-fold | 1 |
| 235 | 21-minute | 1 |
| 236 | 21.3-fold | 1 |
| 237 | 25-40-fold | 1 |
| 238 | 250-molecular | 1 |
| 239 | 28-point | 1 |
| 240 | 28.7-db | 1 |
| 241 | 2½-fold | 1 |
| 242 | 3-dilution | 1 |
| 243 | 3.09-fold | 1 |
| 244 | 3.2-day | 1 |
| 245 | 3.21-fold | 1 |
| 246 | 3.36-log | 1 |
| 247 | 3.4-min | 1 |
| 248 | 3.5-kg | 1 |
| 249 | 3.5-mg/dl | 1 |
| 250 | 3.9-month | 1 |
| 251 | 30p.100 | 1 |
| 252 | 32-millisecond | 1 |
| 253 | 32-minute | 1 |
| 254 | 33-percent | 1 |
| 255 | 34-point | 1 |
| 256 | 35.1-fold | 1 |
| 257 | 35.6-percent | 1 |
| 258 | 36-minute | 1 |
| 259 | 360-fold | 1 |
| 260 | 4-ap-related | 1 |
| 261 | 4.01-fold | 1 |
| 262 | 4.17-log | 1 |
| 263 | 4.3-kg | 1 |
| 264 | 4.33-month | 1 |
| 265 | 4.44-fold | 1 |
| 266 | 4.8-day | 1 |
| 267 | 40-lb | 1 |
| 268 | 4000-fold | 1 |
| 269 | 41.2-ms | 1 |
| 270 | 5-15-fold | 1 |
| 271 | 5-percentage-point | 1 |
| 272 | 5.0-log | 1 |
| 273 | 5.09-point | 1 |
| 274 | 5.1-log | 1 |
| 275 | 5.1-ppb | 1 |
| 276 | 5.25-point | 1 |
| 277 | 5.5-day | 1 |
| 278 | 6-dba | 1 |
| 279 | 64.7-fold | 1 |
| 280 | 6400-fold | 1 |
| 281 | 652-mg | 1 |
| 282 | 7.5-beat/minute | 1 |
| 283 | 7.8-point | 1 |
| 284 | 76-μm | 1 |
| 285 | 77-percent | 1 |
| 286 | 80.3-fold | 1 |
| 287 | 94-fold | 1 |
| 288 | autocatalytically | 1 |
| 289 | baseline-to-3-month | 1 |
| 290 | bath-mats | 1 |
| 291 | biphase | 1 |
| 292 | body-wide | 1 |
| 293 | bumetanide-induced | 1 |
| 294 | cimt-sds | 1 |
| 295 | claer | 1 |
| 296 | close-to-significant | 1 |
| 297 | clpl-dependent | 1 |
| 298 | cotemporal | 1 |
| 299 | cyclodehydration-imine | 1 |
| 300 | decrease/an | 1 |
| 301 | disconcertering | 1 |
| 302 | dose-incremental | 1 |
| 303 | dose-ordered | 1 |
| 304 | double-stepped | 1 |
| 305 | ds-approximal | 1 |
| 306 | earlier-peaking | 1 |
| 307 | five-sixfold | 1 |
| 308 | fortyfold | 1 |
| 309 | furazolidone-susceptible | 1 |
| 310 | gp91phox-mediated | 1 |
| 311 | greater-than-2-fold | 1 |
| 312 | greater-than-observed | 1 |
| 313 | helicopter-towed | 1 |
| 314 | high-negative | 1 |
| 315 | hx-induced | 1 |
| 316 | hydrolysis-induced | 1 |
| 317 | hyperinsulinemia-related | 1 |
| 318 | just-significant | 1 |
| 319 | kv7.5 | 1 |
| 320 | larger-than-median | 1 |
| 321 | lc/hfd-induced | 1 |
| 322 | leep-associated | 1 |
| 323 | less-than-quadratic | 1 |
| 324 | ln-unit | 1 |
| 325 | long-observed | 1 |
| 326 | lv-volume | 1 |
| 327 | markable | 1 |
| 328 | microfilamentous | 1 |
| 329 | moderate-intermediate | 1 |
| 330 | mr-detected | 1 |
| 331 | muscle-thin | 1 |
| 332 | mutated-like | 1 |
| 333 | nanomole | 1 |
| 334 | nearly-significant | 1 |
| 335 | nic+mdma | 1 |
| 336 | non-substantial | 1 |
| 337 | non-survivable | 1 |
| 338 | one-liter | 1 |
| 339 | p-quadratic | 1 |
| 340 | parabola-like | 1 |
| 341 | petrochemically | 1 |
| 342 | phlebotomy-induced | 1 |
| 343 | plr-induced | 1 |
| 344 | polydense | 1 |
| 345 | post-boiling | 1 |
| 346 | postangiographical | 1 |
| 347 | ppar-δ-dependent | 1 |
| 348 | prelethal | 1 |
| 349 | pronouned | 1 |
| 350 | ptc-mediated | 1 |
| 351 | pure-tone-average | 1 |
| 352 | pyrimethanil-induced | 1 |
| 353 | ramipril-induced | 1 |
| 354 | rapider | 1 |
| 355 | reversible/quasi-reversible | 1 |
| 356 | robust- | 1 |
| 357 | rotation-independent | 1 |
| 358 | samplewide | 1 |
| 359 | score-defined | 1 |
| 360 | severity-dependent | 1 |
| 361 | significant.group | 1 |
| 362 | significent | 1 |
| 363 | significnat | 1 |
| 364 | similarl | 1 |
| 365 | stress-deprivation | 1 |
| 366 | substitution-reactive | 1 |
| 367 | supra-proportional | 1 |
| 368 | tdcs-associated | 1 |
| 369 | ten-beat | 1 |
| 370 | thermoregulatory-mediated | 1 |
| 371 | three-serving | 1 |
| 372 | tnfalpha-dependent | 1 |
| 373 | transition-associated | 1 |
| 374 | trend-wise | 1 |
| 375 | two-dilution | 1 |
| 376 | two-log | 1 |
| 377 | unsatifactory | 1 |
| 378 | weight/median | 1 |
| 379 | ~2500-fold | 1 |
| 380 | ~6-12-fold | 1 |
| 381 | ∼4.5-fold | 1 |
| 382 | ≥15-point | 1 |
| 383 | ≥2-log10 | 1 |
| 384 | ≥20-m | 1 |
| 385 | ≥5-unit | 1 |
| 386 | ≥6-point | 1 |
| 1 | 'gfr | 1 |
| 2 | -1sd | 2 |
| 3 | -5-mv | 1 |
| 4 | -5·79 | 1 |
| 5 | -cipiccoc | 2 |
| 6 | .10-mm | 1 |
| 7 | 0.007-mmol/l | 1 |
| 8 | 0.009-mmol/l | 1 |
| 9 | 0.01-s | 1 |
| 10 | 0.03-unit | 1 |
| 11 | 0.06mm | 2 |
| 12 | 0.1-cm | 4 |
| 13 | 0.1-mg/l | 1 |
| 14 | 0.1-unit | 2 |
| 15 | 0.186-point | 1 |
| 16 | 0.2-ph-unit | 1 |
| 17 | 0.2-point | 1 |
| 18 | 0.241-unit | 1 |
| 19 | 0.25-mg/dl | 1 |
| 20 | 0.4-pound | 1 |
| 21 | 0.43-kcal | 1 |
| 22 | 0.5-l | 1 |
| 23 | 0.5-meq/l | 1 |
| 24 | 0.5-mg/dl | 3 |
| 25 | 0.5-mg/l | 1 |
| 26 | 0.5-mm-step | 1 |
| 27 | 0.5-point | 6 |
| 28 | 0.5-unit | 2 |
| 29 | 0.55ng/ml | 1 |
| 30 | 0.5mg/dl | 4 |
| 31 | 0.6-1.0-s | 1 |
| 32 | 0.6-log | 1 |
| 33 | 0.6mmhg | 1 |
| 34 | 0.7-point | 1 |
| 35 | 0.7/1000 | 2 |
| 36 | 0.73-point | 1 |
| 37 | 0.78±0.13 | 1 |
| 38 | 0.8-point | 2 |
| 39 | 0.96-point | 1 |
| 40 | 1,8-cineol-depending | 1 |
| 41 | 1-allele | 1 |
| 42 | 1-beat-per-minute | 1 |
| 43 | 1-g/dl | 3 |
| 44 | 1-grade | 2 |
| 45 | 1-kg | 8 |
| 46 | 1-log | 11 |
| 47 | 1-log-unit | 1 |
| 48 | 1-met | 2 |
| 49 | 1-mg/dl | 7 |
| 50 | 1-mg·h/l | 1 |
| 51 | 1-mmhg | 3 |
| 52 | 1-mug/ml | 1 |
| 53 | 1-natural-log-unit | 2 |
| 54 | 1-ng/ml | 1 |
| 55 | 1-point | 67 |
| 56 | 1-sd | 67 |
| 57 | 1-sd-unit | 1 |
| 58 | 1-unit | 29 |
| 59 | 1.0-meq/l | 1 |
| 60 | 1.0-point | 1 |
| 61 | 1.05-fold | 1 |
| 62 | 1.08-fold | 2 |
| 63 | 1.10-point | 1 |
| 64 | 1.2-1.4-fold | 1 |
| 65 | 1.2-pound | 1 |
| 66 | 1.21-point | 1 |
| 67 | 1.22-g/dl | 1 |
| 68 | 1.25-ml | 1 |
| 69 | 1.3-day | 1 |
| 70 | 1.3-kg | 1 |
| 71 | 1.36-fold | 3 |
| 72 | 1.53-unit | 1 |
| 73 | 1.6-point | 1 |
| 74 | 1.7-db | 1 |
| 75 | 1.8-point | 2 |
| 76 | 1.92-point | 1 |
| 77 | 1.96-fold | 2 |
| 78 | 10-30-fold | 1 |
| 79 | 10-bpm | 2 |
| 80 | 10-cmh2o | 2 |
| 81 | 10-g/l | 1 |
| 82 | 10-letter | 6 |
| 83 | 10-mg/dl | 8 |
| 84 | 10-microg/m3 | 1 |
| 85 | 10-millisecond | 1 |
| 86 | 10-ml/min | 1 |
| 87 | 10-mmhg | 17 |
| 88 | 10-ms | 13 |
| 89 | 10-msec | 4 |
| 90 | 10-nmol/l | 1 |
| 91 | 10-u | 2 |
| 92 | 10-unit | 13 |
| 93 | 10-µg/m3 | 1 |
| 94 | 10-µm | 2 |
| 95 | 10-μg/l | 3 |
| 96 | 100-cell/microl | 1 |
| 97 | 100-cgy | 1 |
| 98 | 100-mmol/d | 1 |
| 99 | 100-mum | 1 |
| 100 | 100-ng/ml | 2 |
| 101 | 100-ru/ml | 1 |
| 102 | 1000-unit | 1 |
| 103 | 1000/microl | 1 |
| 104 | 100pg/ml | 2 |
| 105 | 10minute/night | 1 |
| 106 | 10°f | 6 |
| 107 | 12.5-point | 1 |
| 108 | 13.8-fold | 1 |
| 109 | 14-second | 2 |
| 110 | 14.3-fold | 2 |
| 111 | 15-db | 2 |
| 112 | 15-letter | 12 |
| 113 | 15.5-fold | 1 |
| 114 | 16.3°c | 1 |
| 115 | 17.2-fold | 2 |
| 116 | 17.4-fold | 1 |
| 117 | 19.6-fold | 1 |
| 118 | 1°f | 3 |
| 119 | 2-degree | 1 |
| 120 | 2-grade | 5 |
| 121 | 2-kg | 1 |
| 122 | 2-line | 3 |
| 123 | 2-log | 17 |
| 124 | 2-log10 | 1 |
| 125 | 2-mmhg | 2 |
| 126 | 2-sd | 3 |
| 127 | 2.0-log | 1 |
| 128 | 2.1-kg | 1 |
| 129 | 2.25-fold | 2 |
| 130 | 2.27-point | 1 |
| 131 | 2.4-point | 2 |
| 132 | 2.43-fold | 1 |
| 133 | 2.47/log10 | 1 |
| 134 | 2.5-3-fold | 2 |
| 135 | 2.5-kg | 1 |
| 136 | 2.64-unit | 1 |
| 137 | 2.8-kg | 1 |
| 138 | 2.86-fold | 1 |
| 139 | 20-mmhg | 5 |
| 140 | 21-minute | 1 |
| 141 | 21.3-fold | 1 |
| 142 | 25-40-fold | 1 |
| 143 | 25-mg/dl | 2 |
| 144 | 250-molecular | 1 |
| 145 | 28-point | 1 |
| 146 | 28.7-db | 1 |
| 147 | 2½-fold | 1 |
| 148 | 3-dilution | 1 |
| 149 | 3-line | 5 |
| 150 | 3-log | 17 |
| 151 | 3.09-fold | 1 |
| 152 | 3.1-month | 2 |
| 153 | 3.2-day | 1 |
| 154 | 3.21-fold | 1 |
| 155 | 3.3-point | 2 |
| 156 | 3.36-log | 1 |
| 157 | 3.4-min | 1 |
| 158 | 3.5-kg | 1 |
| 159 | 3.5-mg/dl | 1 |
| 160 | 3.6-day | 2 |
| 161 | 3.74-fold | 2 |
| 162 | 3.9-month | 1 |
| 163 | 3.94-fold | 2 |
| 164 | 30-mmhg | 2 |
| 165 | 30p.100 | 1 |
| 166 | 32-millisecond | 1 |
| 167 | 32-minute | 1 |
| 168 | 33-percent | 1 |
| 169 | 34-point | 1 |
| 170 | 35.1-fold | 1 |
| 171 | 35.6-percent | 1 |
| 172 | 350-fold | 2 |
| 173 | 36-minute | 1 |
| 174 | 360-fold | 1 |
| 175 | 4-ap-related | 1 |
| 176 | 4-log | 9 |
| 177 | 4.01-fold | 1 |
| 178 | 4.1-month | 4 |
| 179 | 4.17-log | 1 |
| 180 | 4.3-kg | 1 |
| 181 | 4.33-month | 1 |
| 182 | 4.36-fold | 2 |
| 183 | 4.44-fold | 1 |
| 184 | 4.5-log | 4 |
| 185 | 4.8-day | 1 |
| 186 | 40-lb | 1 |
| 187 | 400-g | 2 |
| 188 | 4000-fold | 1 |
| 189 | 41.2-ms | 1 |
| 190 | 450-bp | 3 |
| 191 | 5-15-fold | 1 |
| 192 | 5-beat | 3 |
| 193 | 5-bpm | 4 |
| 194 | 5-kg | 7 |
| 195 | 5-log | 31 |
| 196 | 5-mmhg | 8 |
| 197 | 5-ms | 3 |
| 198 | 5-percentage-point | 1 |
| 199 | 5-unit | 7 |
| 200 | 5.0-log | 1 |
| 201 | 5.09-point | 1 |
| 202 | 5.1-log | 1 |
| 203 | 5.1-ppb | 1 |
| 204 | 5.25-point | 1 |
| 205 | 5.26-fold | 2 |
| 206 | 5.5-day | 1 |
| 207 | 50-hu | 2 |
| 208 | 6-dba | 1 |
| 209 | 6-log | 4 |
| 210 | 6-unit | 2 |
| 211 | 63-fold | 2 |
| 212 | 64.7-fold | 1 |
| 213 | 6400-fold | 1 |
| 214 | 652-mg | 1 |
| 215 | 7-log | 5 |
| 216 | 7.5-beat/minute | 1 |
| 217 | 7.5-day | 2 |
| 218 | 7.8-point | 1 |
| 219 | 74-fold | 3 |
| 220 | 76-μm | 1 |
| 221 | 77-percent | 1 |
| 222 | 80.3-fold | 1 |
| 223 | 9-log | 2 |
| 224 | 94-fold | 1 |
| 225 | autocatalytically | 1 |
| 226 | baseline-to-3-month | 1 |
| 227 | bath-mats | 1 |
| 228 | biphase | 1 |
| 229 | body-wide | 1 |
| 230 | bumetanide-induced | 1 |
| 231 | candesartan-mediated | 2 |
| 232 | cimt-sds | 1 |
| 233 | claer | 1 |
| 234 | close-to-significant | 1 |
| 235 | clpl-dependent | 1 |
| 236 | colorectostomy | 2 |
| 237 | cotemporal | 1 |
| 238 | cyclodehydration-imine | 1 |
| 239 | decrease/an | 1 |
| 240 | direct-to-indirect | 2 |
| 241 | disconcertering | 1 |
| 242 | disease-attributable | 2 |
| 243 | disproportional | 18 |
| 244 | dose-dependant | 4 |
| 245 | dose-incremental | 1 |
| 246 | dose-ordered | 1 |
| 247 | double-stepped | 1 |
| 248 | drug-independent | 2 |
| 249 | ds-approximal | 1 |
| 250 | dust-mite | 3 |
| 251 | earlier-peaking | 1 |
| 252 | fifteen-fold | 2 |
| 253 | five-sixfold | 1 |
| 254 | five-unit | 4 |
| 255 | fortyfold | 1 |
| 256 | furazolidone-susceptible | 1 |
| 257 | galactogogue | 10 |
| 258 | gp91phox-mediated | 1 |
| 259 | greater-than-2-fold | 1 |
| 260 | greater-than-observed | 1 |
| 261 | helicopter-towed | 1 |
| 262 | high-negative | 1 |
| 263 | hx-induced | 1 |
| 264 | hydrolysis-induced | 1 |
| 265 | hyperinsulinemia-related | 1 |
| 266 | just-significant | 1 |
| 267 | kv7.5 | 1 |
| 268 | l-nmma-induced | 2 |
| 269 | larger-than-median | 1 |
| 270 | lc/hfd-induced | 1 |
| 271 | leep-associated | 1 |
| 272 | less-than-quadratic | 1 |
| 273 | lf-diet | 3 |
| 274 | limb- | 2 |
| 275 | lipohemarthrosis | 2 |
| 276 | ln-unit | 1 |
| 277 | long-observed | 1 |
| 278 | luxated | 2 |
| 279 | lv-volume | 1 |
| 280 | markable | 1 |
| 281 | mechanically-induced | 4 |
| 282 | microfilamentous | 1 |
| 283 | mobilizable | 3 |
| 284 | moderate-intermediate | 1 |
| 285 | moderate-to-marked | 2 |
| 286 | modest | 3,716 |
| 287 | mr-detected | 1 |
| 288 | muscle-thin | 1 |
| 289 | mutated-like | 1 |
| 290 | nanomole | 1 |
| 291 | near-significant | 19 |
| 292 | nearly-significant | 1 |
| 293 | nic+mdma | 1 |
| 294 | nine-fold | 5 |
| 295 | non-significant | 1,586 |
| 296 | non-substantial | 1 |
| 297 | non-survivable | 1 |
| 298 | nonsignificant | 1,473 |
| 299 | one-category | 6 |
| 300 | one-liter | 1 |
| 301 | one-point | 27 |
| 302 | one-standard-deviation | 2 |
| 303 | one-unit | 17 |
| 304 | p-quadratic | 1 |
| 305 | parabola-like | 1 |
| 306 | passable | 5 |
| 307 | petrochemically | 1 |
| 308 | phlebotomy-induced | 1 |
| 309 | plr-induced | 1 |
| 310 | polydense | 1 |
| 311 | polylactide-based | 2 |
| 312 | post-boiling | 1 |
| 313 | post-hypothermic | 2 |
| 314 | postangiographical | 1 |
| 315 | ppar-δ-dependent | 1 |
| 316 | prelethal | 1 |
| 317 | pronouned | 1 |
| 318 | ptc-mediated | 1 |
| 319 | pure-tone-average | 1 |
| 320 | pyrimethanil-induced | 1 |
| 321 | ramipril-induced | 1 |
| 322 | rapider | 1 |
| 323 | record-breaking | 6 |
| 324 | redofundoplication | 2 |
| 325 | reversible/quasi-reversible | 1 |
| 326 | rhytid | 3 |
| 327 | robust- | 1 |
| 328 | rotation-independent | 1 |
| 329 | sampen | 5 |
| 330 | samplewide | 1 |
| 331 | score-defined | 1 |
| 332 | scr-level | 2 |
| 333 | ser37 | 5 |
| 334 | severity-dependent | 1 |
| 335 | significant.group | 1 |
| 336 | significent | 1 |
| 337 | significnat | 1 |
| 338 | silicone-covered | 2 |
| 339 | similarl | 1 |
| 340 | slight | 2,147 |
| 341 | small-moderate | 9 |
| 342 | small-to-large | 2 |
| 343 | small-to-moderate | 28 |
| 344 | stress-deprivation | 1 |
| 345 | stroke-risk | 2 |
| 346 | sub-additive | 4 |
| 347 | sub-proportional | 2 |
| 348 | substitution-reactive | 1 |
| 349 | superlative | 3 |
| 350 | supra-proportional | 1 |
| 351 | t-score≤-2.5 | 4 |
| 352 | tdcs-associated | 1 |
| 353 | ten-beat | 1 |
| 354 | teriparatide-induced | 3 |
| 355 | thermoregulatory-mediated | 1 |
| 356 | three-serving | 1 |
| 357 | tnfalpha-dependent | 1 |
| 358 | transition-associated | 1 |
| 359 | trend-level | 9 |
| 360 | trend-wise | 1 |
| 361 | two-dilution | 1 |
| 362 | two-grade | 3 |
| 363 | two-log | 1 |
| 364 | unsatifactory | 1 |
| 365 | wedge-shaped | 11 |
| 366 | weight/median | 1 |
| 367 | well-marked | 2 |
| 368 | ~2500-fold | 1 |
| 369 | ~6-12-fold | 1 |
| 370 | ∼2.5-fold | 2 |
| 371 | ∼4.5-fold | 1 |
| 372 | ∼7-fold | 2 |
| 373 | ≥1-point | 9 |
| 374 | ≥1/3 | 2 |
| 375 | ≥15-letter | 8 |
| 376 | ≥15-point | 1 |
| 377 | ≥2-log | 3 |
| 378 | ≥2-log10 | 1 |
| 379 | ≥2-point | 6 |
| 380 | ≥20-m | 1 |
| 381 | ≥20-point | 2 |
| 382 | ≥3-fold | 2 |
| 383 | ≥4-fold | 29 |
| 384 | ≥5-unit | 1 |
| 385 | ≥6-point | 1 |
| 386 | ≥8-point | 2 |
| 1 | limb- | 2 |
| 2 | robust- | 1 |
| 3 | 0.7/1000 | 2 |
| 4 | 30p.100 | 1 |
| 5 | 2-log10 | 1 |
| 6 | ≥2-log10 | 1 |
| 7 | 2.47/log10 | 1 |
| 8 | ≥1/3 | 2 |
| 9 | 0.78±0.13 | 1 |
| 10 | 10-microg/m3 | 1 |
| 11 | 10-µg/m3 | 1 |
| 12 | t-score≤-2.5 | 4 |
| 13 | kv7.5 | 1 |
| 14 | ser37 | 5 |
| 15 | -5·79 | 1 |
| 16 | 6-dba | 1 |
| 17 | nic+mdma | 1 |
| 18 | 15-db | 2 |
| 19 | 1.7-db | 1 |
| 20 | 28.7-db | 1 |
| 21 | 40-lb | 1 |
| 22 | 5.1-ppb | 1 |
| 23 | 10-msec | 4 |
| 24 | post-hypothermic | 2 |
| 25 | less-than-quadratic | 1 |
| 26 | p-quadratic | 1 |
| 27 | -cipiccoc | 2 |
| 28 | 16.3°c | 1 |
| 29 | 100-mmol/d | 1 |
| 30 | l-nmma-induced | 2 |
| 31 | lc/hfd-induced | 1 |
| 32 | bumetanide-induced | 1 |
| 33 | teriparatide-induced | 3 |
| 34 | pyrimethanil-induced | 1 |
| 35 | ramipril-induced | 1 |
| 36 | plr-induced | 1 |
| 37 | hydrolysis-induced | 1 |
| 38 | hx-induced | 1 |
| 39 | mechanically-induced | 4 |
| 40 | phlebotomy-induced | 1 |
| 41 | well-marked | 2 |
| 42 | moderate-to-marked | 2 |
| 43 | score-defined | 1 |
| 44 | pronouned | 1 |
| 45 | wedge-shaped | 11 |
| 46 | double-stepped | 1 |
| 47 | dose-ordered | 1 |
| 48 | silicone-covered | 2 |
| 49 | polylactide-based | 2 |
| 50 | transition-associated | 1 |
| 51 | leep-associated | 1 |
| 52 | tdcs-associated | 1 |
| 53 | ptc-mediated | 1 |
| 54 | candesartan-mediated | 2 |
| 55 | gp91phox-mediated | 1 |
| 56 | thermoregulatory-mediated | 1 |
| 57 | hyperinsulinemia-related | 1 |
| 58 | 4-ap-related | 1 |
| 59 | luxated | 2 |
| 60 | mr-detected | 1 |
| 61 | long-observed | 1 |
| 62 | greater-than-observed | 1 |
| 63 | helicopter-towed | 1 |
| 64 | rhytid | 3 |
| 65 | 4000-fold | 1 |
| 66 | 6400-fold | 1 |
| 67 | ~2500-fold | 1 |
| 68 | 10-30-fold | 1 |
| 69 | 25-40-fold | 1 |
| 70 | 350-fold | 2 |
| 71 | 360-fold | 1 |
| 72 | 35.1-fold | 1 |
| 73 | 4.01-fold | 1 |
| 74 | 3.21-fold | 1 |
| 75 | greater-than-2-fold | 1 |
| 76 | 17.2-fold | 2 |
| 77 | ~6-12-fold | 1 |
| 78 | 2.5-3-fold | 2 |
| 79 | 80.3-fold | 1 |
| 80 | 21.3-fold | 1 |
| 81 | 14.3-fold | 2 |
| 82 | 2.43-fold | 1 |
| 83 | 63-fold | 2 |
| 84 | ≥3-fold | 2 |
| 85 | 1.2-1.4-fold | 1 |
| 86 | 17.4-fold | 1 |
| 87 | 4.44-fold | 1 |
| 88 | 74-fold | 3 |
| 89 | 3.74-fold | 2 |
| 90 | 94-fold | 1 |
| 91 | 3.94-fold | 2 |
| 92 | ≥4-fold | 29 |
| 93 | ∼2.5-fold | 2 |
| 94 | ∼4.5-fold | 1 |
| 95 | 15.5-fold | 1 |
| 96 | 1.05-fold | 1 |
| 97 | 5-15-fold | 1 |
| 98 | 2.25-fold | 2 |
| 99 | 19.6-fold | 1 |
| 100 | 5.26-fold | 2 |
| 101 | 1.36-fold | 3 |
| 102 | 4.36-fold | 2 |
| 103 | 2.86-fold | 1 |
| 104 | 1.96-fold | 2 |
| 105 | 64.7-fold | 1 |
| 106 | ∼7-fold | 2 |
| 107 | 13.8-fold | 1 |
| 108 | 1.08-fold | 2 |
| 109 | 3.09-fold | 1 |
| 110 | nine-fold | 5 |
| 111 | fifteen-fold | 2 |
| 112 | 2½-fold | 1 |
| 113 | five-sixfold | 1 |
| 114 | fortyfold | 1 |
| 115 | 14-second | 2 |
| 116 | 10-millisecond | 1 |
| 117 | 32-millisecond | 1 |
| 118 | 1.2-pound | 1 |
| 119 | 0.4-pound | 1 |
| 120 | 1-sd | 67 |
| 121 | 2-sd | 3 |
| 122 | -1sd | 2 |
| 123 | 1-grade | 2 |
| 124 | 2-grade | 5 |
| 125 | two-grade | 3 |
| 126 | body-wide | 1 |
| 127 | samplewide | 1 |
| 128 | 2-degree | 1 |
| 129 | pure-tone-average | 1 |
| 130 | small-to-large | 2 |
| 131 | parabola-like | 1 |
| 132 | mutated-like | 1 |
| 133 | markable | 1 |
| 134 | passable | 5 |
| 135 | disease-attributable | 2 |
| 136 | non-survivable | 1 |
| 137 | mobilizable | 3 |
| 138 | reversible/quasi-reversible | 1 |
| 139 | furazolidone-susceptible | 1 |
| 140 | 1-allele | 1 |
| 141 | nanomole | 1 |
| 142 | lv-volume | 1 |
| 143 | 2-line | 3 |
| 144 | 3-line | 5 |
| 145 | cyclodehydration-imine | 1 |
| 146 | biphase | 1 |
| 147 | trend-wise | 1 |
| 148 | polydense | 1 |
| 149 | moderate-intermediate | 1 |
| 150 | small-moderate | 9 |
| 151 | small-to-moderate | 28 |
| 152 | dust-mite | 3 |
| 153 | 21-minute | 1 |
| 154 | 32-minute | 1 |
| 155 | 36-minute | 1 |
| 156 | 1-beat-per-minute | 1 |
| 157 | 7.5-beat/minute | 1 |
| 158 | galactogogue | 10 |
| 159 | high-negative | 1 |
| 160 | superlative | 3 |
| 161 | substitution-reactive | 1 |
| 162 | sub-additive | 4 |
| 163 | 10°f | 6 |
| 164 | 1°f | 3 |
| 165 | 400-g | 2 |
| 166 | 10-mmhg | 17 |
| 167 | 20-mmhg | 5 |
| 168 | 30-mmhg | 2 |
| 169 | 1-mmhg | 3 |
| 170 | 2-mmhg | 2 |
| 171 | 5-mmhg | 8 |
| 172 | 0.6mmhg | 1 |
| 173 | 1-kg | 8 |
| 174 | 2.1-kg | 1 |
| 175 | 2-kg | 1 |
| 176 | 1.3-kg | 1 |
| 177 | 4.3-kg | 1 |
| 178 | 5-kg | 7 |
| 179 | 2.5-kg | 1 |
| 180 | 3.5-kg | 1 |
| 181 | 2.8-kg | 1 |
| 182 | 652-mg | 1 |
| 183 | 1,8-cineol-depending | 1 |
| 184 | earlier-peaking | 1 |
| 185 | record-breaking | 6 |
| 186 | post-boiling | 1 |
| 187 | disconcertering | 1 |
| 188 | three-serving | 1 |
| 189 | 2.0-log | 1 |
| 190 | 5.0-log | 1 |
| 191 | 1-log | 11 |
| 192 | 5.1-log | 1 |
| 193 | 2-log | 17 |
| 194 | ≥2-log | 3 |
| 195 | 3-log | 17 |
| 196 | 4-log | 9 |
| 197 | 5-log | 31 |
| 198 | 4.5-log | 4 |
| 199 | 6-log | 4 |
| 200 | 0.6-log | 1 |
| 201 | 3.36-log | 1 |
| 202 | 7-log | 5 |
| 203 | 4.17-log | 1 |
| 204 | 9-log | 2 |
| 205 | two-log | 1 |
| 206 | 3.1-month | 2 |
| 207 | 4.1-month | 4 |
| 208 | baseline-to-3-month | 1 |
| 209 | 4.33-month | 1 |
| 210 | 3.9-month | 1 |
| 211 | stroke-risk | 2 |
| 212 | 0.5-l | 1 |
| 213 | 10-g/l | 1 |
| 214 | 0.1-mg/l | 1 |
| 215 | 0.5-mg/l | 1 |
| 216 | 10-μg/l | 3 |
| 217 | 1-mg·h/l | 1 |
| 218 | 0.007-mmol/l | 1 |
| 219 | 0.009-mmol/l | 1 |
| 220 | 10-nmol/l | 1 |
| 221 | 1.0-meq/l | 1 |
| 222 | 0.5-meq/l | 1 |
| 223 | postangiographical | 1 |
| 224 | 0.43-kcal | 1 |
| 225 | prelethal | 1 |
| 226 | non-substantial | 1 |
| 227 | ds-approximal | 1 |
| 228 | supra-proportional | 1 |
| 229 | sub-proportional | 2 |
| 230 | disproportional | 18 |
| 231 | cotemporal | 1 |
| 232 | dose-incremental | 1 |
| 233 | 1-g/dl | 3 |
| 234 | 1.22-g/dl | 1 |
| 235 | 10-mg/dl | 8 |
| 236 | 1-mg/dl | 7 |
| 237 | 0.5-mg/dl | 3 |
| 238 | 3.5-mg/dl | 1 |
| 239 | 25-mg/dl | 2 |
| 240 | 0.25-mg/dl | 1 |
| 241 | 0.5mg/dl | 4 |
| 242 | trend-level | 9 |
| 243 | scr-level | 2 |
| 244 | 1.25-ml | 1 |
| 245 | 100-ng/ml | 2 |
| 246 | 1-ng/ml | 1 |
| 247 | 0.55ng/ml | 1 |
| 248 | 100pg/ml | 2 |
| 249 | 1-mug/ml | 1 |
| 250 | 100-ru/ml | 1 |
| 251 | 1000/microl | 1 |
| 252 | 100-cell/microl | 1 |
| 253 | similarl | 1 |
| 254 | ≥20-m | 1 |
| 255 | 0.1-cm | 4 |
| 256 | .10-mm | 1 |
| 257 | 0.06mm | 2 |
| 258 | 10-bpm | 2 |
| 259 | 5-bpm | 4 |
| 260 | 100-mum | 1 |
| 261 | 10-µm | 2 |
| 262 | 76-μm | 1 |
| 263 | decrease/an | 1 |
| 264 | larger-than-median | 1 |
| 265 | weight/median | 1 |
| 266 | sampen | 5 |
| 267 | muscle-thin | 1 |
| 268 | 3.4-min | 1 |
| 269 | 10-ml/min | 1 |
| 270 | redofundoplication | 2 |
| 271 | one-standard-deviation | 2 |
| 272 | stress-deprivation | 1 |
| 273 | 3-dilution | 1 |
| 274 | two-dilution | 1 |
| 275 | 10-cmh2o | 2 |
| 276 | 450-bp | 3 |
| 277 | 0.5-mm-step | 1 |
| 278 | significant.group | 1 |
| 279 | 250-molecular | 1 |
| 280 | claer | 1 |
| 281 | rapider | 1 |
| 282 | one-liter | 1 |
| 283 | 10-letter | 6 |
| 284 | 15-letter | 12 |
| 285 | ≥15-letter | 8 |
| 286 | 'gfr | 1 |
| 287 | 0.6-1.0-s | 1 |
| 288 | 0.01-s | 1 |
| 289 | cimt-sds | 1 |
| 290 | lipohemarthrosis | 2 |
| 291 | 10-ms | 13 |
| 292 | 41.2-ms | 1 |
| 293 | 5-ms | 3 |
| 294 | bath-mats | 1 |
| 295 | microfilamentous | 1 |
| 296 | 5-beat | 3 |
| 297 | ten-beat | 1 |
| 298 | significnat | 1 |
| 299 | direct-to-indirect | 2 |
| 300 | lf-diet | 3 |
| 301 | 1-met | 2 |
| 302 | slight | 2,147 |
| 303 | 10minute/night | 1 |
| 304 | 1000-unit | 1 |
| 305 | 10-unit | 13 |
| 306 | 1-unit | 29 |
| 307 | 0.1-unit | 2 |
| 308 | 0.241-unit | 1 |
| 309 | 0.03-unit | 1 |
| 310 | 1.53-unit | 1 |
| 311 | 2.64-unit | 1 |
| 312 | 5-unit | 7 |
| 313 | 0.5-unit | 2 |
| 314 | ≥5-unit | 1 |
| 315 | 6-unit | 2 |
| 316 | 1-sd-unit | 1 |
| 317 | one-unit | 17 |
| 318 | five-unit | 4 |
| 319 | 1-log-unit | 1 |
| 320 | 1-natural-log-unit | 2 |
| 321 | 0.2-ph-unit | 1 |
| 322 | ln-unit | 1 |
| 323 | non-significant | 1,586 |
| 324 | close-to-significant | 1 |
| 325 | near-significant | 19 |
| 326 | just-significant | 1 |
| 327 | nearly-significant | 1 |
| 328 | nonsignificant | 1,473 |
| 329 | dose-dependant | 4 |
| 330 | significent | 1 |
| 331 | 33-percent | 1 |
| 332 | 35.6-percent | 1 |
| 333 | 77-percent | 1 |
| 334 | tnfalpha-dependent | 1 |
| 335 | clpl-dependent | 1 |
| 336 | severity-dependent | 1 |
| 337 | ppar-δ-dependent | 1 |
| 338 | drug-independent | 2 |
| 339 | rotation-independent | 1 |
| 340 | 1.0-point | 1 |
| 341 | 1.10-point | 1 |
| 342 | ≥20-point | 2 |
| 343 | 1-point | 67 |
| 344 | 1.21-point | 1 |
| 345 | ≥1-point | 9 |
| 346 | 0.2-point | 1 |
| 347 | 1.92-point | 1 |
| 348 | ≥2-point | 6 |
| 349 | 3.3-point | 2 |
| 350 | 0.73-point | 1 |
| 351 | 2.4-point | 2 |
| 352 | 34-point | 1 |
| 353 | 0.5-point | 6 |
| 354 | 12.5-point | 1 |
| 355 | ≥15-point | 1 |
| 356 | 5.25-point | 1 |
| 357 | 1.6-point | 1 |
| 358 | 0.186-point | 1 |
| 359 | 0.96-point | 1 |
| 360 | ≥6-point | 1 |
| 361 | 0.7-point | 1 |
| 362 | 2.27-point | 1 |
| 363 | 0.8-point | 2 |
| 364 | 1.8-point | 2 |
| 365 | 7.8-point | 1 |
| 366 | 28-point | 1 |
| 367 | ≥8-point | 2 |
| 368 | 5.09-point | 1 |
| 369 | 5-percentage-point | 1 |
| 370 | one-point | 27 |
| 371 | modest | 3,716 |
| 372 | 10-u | 2 |
| 373 | 50-hu | 2 |
| 374 | -5-mv | 1 |
| 375 | 3.2-day | 1 |
| 376 | 1.3-day | 1 |
| 377 | 5.5-day | 1 |
| 378 | 7.5-day | 2 |
| 379 | 3.6-day | 2 |
| 380 | 4.8-day | 1 |
| 381 | 100-cgy | 1 |
| 382 | petrochemically | 1 |
| 383 | autocatalytically | 1 |
| 384 | colorectostomy | 2 |
| 385 | one-category | 6 |
| 386 | unsatifactory | 1 |